Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-01 Sale | 2026-09-03 7:01 pm | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $37.83 | $126,078 | 105,497 (Direct) | View |
| 2026-08-03 Sale | 2026-08-05 7:00 pm | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,334 | $34.47 | $114,920 | 114,057 (Direct) | View |
| 2026-07-01 Sale | 2026-07-02 7:00 pm | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $34.36 | $114,528 | 103,455 (Direct) | View |
| 2026-06-22 Sale | 2026-06-24 7:24 pm | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 15,000 | $35.51 | $532,582 | 132,317 (Direct) | View |
| 2025-11-10 Sale | 2025-11-13 8:13 pm | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,501 | $18.06 | $63,223 | 92,911 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-01 Exercise | 2026-09-03 7:01 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $2.76 | 105,497 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 7:01 pm | N/A 2034-03-19 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $0 | 105,497 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-05 7:00 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,334 | $2.76 | 114,057 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-05 7:00 pm | N/A 2033-11-11 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,334 | $0 | 114,057 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 7:00 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $2.76 | 103,455 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 7:00 pm | N/A 2033-11-11 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 3,333 | $0 | 103,455 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 7:24 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 4,471 | $11.7 | 132,317 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 7:24 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 10,529 | $2.76 | 132,317 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 7:24 pm | N/A 2033-11-11 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 15,000 | $0 | 132,317 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 7:17 pm | N/A 2036-02-05 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 80,000 | $0 | 80,000 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-11 7:03 pm | N/A 2035-08-06 | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2024-10-24 9:20 pm | N/A N/A | Septerna Inc. | SEPN | Long Daniel D. SVP, Drug Discovery | 0 | $0 | 168,400 (Direct) | View |